Hepatitis C virus (HCV) antibody dynamics following acute HCV infection and reinfection among hiv-infected men who have sex with men

Clinical Infectious Diseases

Volumn 59, Issue 12, 2014, Pages 1678-1685

  Vanhommerig, Joost W ^a,b   Thomas, Xiomara V ^a   Van Der Meer, Jan T M ^c   Geskus, Ronald B ^b,d   Bruisten, Sylvia M ^b   Molenkamp, Richard ^a   Prins, Maria ^b,c   Schinkel, Janke ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Health Service Amsterdam   (United States)

^c Internal Medicine Division of Infectious Diseases Center for Infection and Immunity Amsterdam   (United States)

^d Biostatistics and Bioinformatics ^*  (Netherlands)

Author keywords

acute HCV; HCV reinfection; HIV HCV coinfection; men who have sex with men

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C VIRUS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS RNA; HEPATITIS C ANTIBODY;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; FOLLOW UP; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; REINFECTION; SEROCONVERSION; TIME; BLOOD; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE HOMOSEXUALITY; MIDDLE AGED; MIXED INFECTION;

ADULT; COINFECTION; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE AGED;

EID: 84919930322     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu695     Document Type: Article

References (40)

1. Mohd HK, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013; 57:1333-42.
2. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005; 5:558-67.
3. Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 2006; 13:34-41.
4. Vandelli C, Renzo F, Romano L, et al. Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study. Am J Gastroenterol 2004; 99:855-9.
5. Fierer DS. Epidemic of sexually transmitted hepatitis C virus infection among HIV-infected men. Curr Infect Dis Rep 2010; 12:118-25.
6. Danta M, Rodger AJ. Transmission of HCV in HIV-positive populations. Curr Opin HIV AIDS 2011; 6:451-8.
7. Van de Laar TJ, Matthews GV, Prins M, Danta M. Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection. AIDS 2010; 24:1799.812.
8. Van der Helm JJ, Prins M, del Amo J, et al. The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007. AIDS 2011; 25:1083.91.
9. Van de Laar TJ, van der Bij AK, Prins M, et al. Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. J Infect Dis 2007; 196:230.8.
10. Larsen C, Chaix ML, Le SY, et al. Gaining greater insight into HCV emergence in HIV-infected men who have sex with men: the HEPAIG Study. PLoS One 2011; 6:e29322.
11. Urbanus AT, van de Laar TJ, Stolte IG, et al. Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS 2009; 23:F1.7.
12. Busch MP. Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients. Transfus Clin Biol 2001; 8:200.6.
13. Dodd RY, Notari EP, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002; 42:975.9.
14. Page-Shafer K, Pappalardo BL, Tobler LH, et al. Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates. J Clin Microbiol 2008; 46:499.506.
15. Glynn SA,Wright DJ, Kleinman SH, et al. Dynamics of viremia in early hepatitis C virus infection. Transfusion 2005; 45:994.1002.
16. Cox AL, Netski DM, Mosbruger T, et al. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin Infect Dis 2005; 40:951.8.
17. Netski DM, Mosbruger T, Depla E, et al. Humoral immune response in acute hepatitis C virus infection. Clin Infect Dis 2005; 41:667.75.
18. Thomson EC, Nastouli E, Main J, et al. Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS 2009; 23:89.93.
19. Kee KM, Wang JH, Hung CH, et al. Decreased anti-HCV titer and associated factors in chronic hepatitis C patients after sustained virological response: a prospective study. J Gastroenterol Hepatol 2012; 27:1106.11.
20. Lefrere JJ, Guiramand S, Lefrere F, et al. Full or partial seroreversion in patients infected by hepatitis C virus. J Infect Dis 1997; 175:316.22.
21. Strasak AM, Kim AY, Lauer GM, et al. Antibody dynamics and spontaneous viral clearance in patients with acute hepatitis C infection in Rio de Janeiro, Brazil. BMC Infect Dis 2011; 11:15.
22. Toyoda H, Kumada T, Kiriyama S, et al. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy. Clin Infect Dis 2005; 40:e49.54.
23. Takaki A, Wiese M, Maertens G, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 2000; 6:578.82.
24. Hung CH, Lu SN, Wang JH, et al. Identified cases of acute hepatitis C from computerized laboratory database: a hospital-based epidemiological and clinical study. J Infect 2008; 56:274.80.
25. Kondili LA, Chionne P, Costantino A, et al. Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut 2002; 50:693.6.
26. Lanotte P, Dubois F, Le PS, et al. The kinetics of antibodies against hepatitis C virus may predict viral clearance in exposed hemophiliacs. J Infect Dis 1998; 178:556.9.
27. Ragni MV, Ndimbie OK, Rice EO, Bontempo FA, Nedjar S. The presence of hepatitis C virus (HCV) antibody in human immunodeficiency virus-positive hemophilic men undergoing HCV ?gseroreversion.? Blood 1993; 82:1010.5.
28. Pawlotsky JM. Use and interpretation of virological tests for hepatitis C. Hepatology 2002; 36(5 suppl 1):S65.73.
29. Chamot E, Hirschel B, Wintsch J, et al. Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users. AIDS 1990; 4:1275.7.
30. Garcia-Costa J, Romero PA, Soriano V, Sheldon J, Toro C. Seroreversion of hepatitis C virus (HCV) antibodies in an HIV-infected patient despite continuous HCV replication. Clin Infect Dis 2009; 48:1634.5.
31. Vaghefi P, Roque-Afonso AM, Dussaix E. Rapid seroreversion following spontaneous recovery of acute hepatitis C in an HIV infected patient [in French]. Pathol Biol (Paris) 2006; 54:347.8.
32. Lambers FA, Prins M, Thomas X, et al. Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM. AIDS 2011; 25:F21.7.
33. Martin TC, Martin NK, Hickman M, et al. HCV reinfection incidence and treatment outcome among HIV-positive MSM in London. AIDS 2013; 27:2551.7.
34. Murphy DG, Willems B, Deschenes M, Hilzenrat N, Mousseau R, Sabbah S. Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5?' untranslated region sequences. J Clin Microbiol 2007; 45:1102.12.
35. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2013. Available at: http://www.R-project.org/. Accessed 23 December 2013.
36. Wiegand J, Jackel E, Cornberg M, et al. Long-term follow-up after successful interferon therapy of acute hepatitis C. Hepatology 2004; 40:98.107.
37. Moir S, Malaspina A, Ho J, et al. Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease. J Infect Dis 2008; 197:572.9.
38. Coker WJ, Jeter A, Schade H, Kang Y. Plasma cell disorders in HIVinfected patients: epidemiology and molecular mechanisms. Biomark Res 2013; 1:8.
39. Mizukoshi E, Eisenbach C, Edlin BR, et al. Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV. J Infect Dis 2008; 198:203.12.
40. Logvinoff C, Major ME, Oldach D, et al. Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc Natl Acad Sci U S A 2004; 101:10149.54.